US OptionsDetailed Quotes
PFE250103P27000
- 0.41
- +0.05+13.89%
15min DelayClose Jan 3 16:00 ET
0.49High0.22Low
0.40Open0.36Pre Close866 Volume1.05K Open Interest27.00Strike Price31.21KTurnover1035.40%IV0.00%PremiumJan 3, 2025Expiry Date0.41Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9016Delta0.5334Gamma60.43Leverage Ratio-54.2622Theta0.0000Rho-54.49Eff Leverage0.0001Vega
Pfizer Stock Discussion
Updates with response from Bristol-Myers Squibb in the fourth and fifth paragraphs.
Drugmakers including Pfizer (PFE), Bristol-Myers Squibb (BMY) and Sanofi (SNY) plan to raise US list prices on at least 250 branded medications, including COVID-19 treatments, cancer cell therapies and vaccines, at the start of 2025, Reuters reported Tuesday, citing data from the healthcare research firm 3 Axis Advisors.
Most of the price hikes are below 10% and are to list prices, which do not i...
Go Go Go
Atavistik Bio Has Entered Into A Research Collaboration With Pfizer For Precision Allosteric Therapeutics, Leveraging Atavistik Bio's Platform To Identify And Validate Allosteric Binders Against Two Undisclosed, Pfizer-designated Targets, Financial Terms Were Not Disclosed.
Youtube Here --->TOPNAVS <--- Click For External Page.
Get Related Content Below. Visit my Youtube For Dedicated Watchlists.
Crown Electrokinetics (CRKN): 2025 Stock Split Vote & Price Target.
Canoo (GOEV): 2024 Reverse Split – Revival or Ruin?
CVS Stock Explained and Pharmacy Benefit Managers.
Please Click The Link To Watch From Youtube. You'll Be Supporting ...
Shortly after close, the $S&P 500 Index (.SPX.US)$ dipped 0.43% to 5,881.63, the $Dow Jones Industrial Average (.DJI.US)$ edged down 0.07% to 42,544.22, and the $Nasdaq Composite Index (.IXIC.US)$ dropped 0.9% to 19,310.79.
For the year, the Nasdaq Composite led the way, rising 29%. The S&P 500 was up 23% (a second straight year of 20% gains) and the Dow added almost 13%.
MACR...
Run for the last mile of 2024! Go Go Go
No comment yet